Itolizumab: Psoriasis Injection Approved for COVID 19 by DCGI

    Itolizumab, a medicine used for the cure of skin ailment psoriasis in India has been authorised by the Indian Drug Regulator in order to treat COVID-19 patients with mild to severe acute respiratory distress.

    Considering the medical requirements of COVID-19 not met, Drugs General Controller, Dr V G. Somani, has approved the monoclonal antibody injection of Biocon Itolizumab to treat the “cytokine” syndrome of release in patients with moderate to severe acute air distress syndrome due to COVID- 19, they said. 

    “The approval was issued by the expert committee, consisting of pulmonologists, pharmacologists and AIIMS medical specialists to treat cytokine release syndrome, after its clinical trials on COVID-19 patients in India, among other things.” an official told PTI.

    “The Biocon medication has already been licensed for several years to treat psoriasis,” said the official.

    Before the use of this drug, signed consent of the patient is required, he said.

    Latest articles

    123Movies | 123movie | 123 movies | 123movies websites – Watch HD Movies Online Free

    123movies contains web-based films and shows. The best place to watch movies for free is 123 movies. 123movies websites provide the highest quality streaming...

    How to Change WiFi Password if Myfiosgateway Not Working?

    By using Myfiosgateway, a Verizon Router, users are able to transmit various digital media and other details to other computers in their offices or...

    What is The Best 5GHz Channel For Your Router? (2021)

    It might be known to many users that 36, 40, 44, 48 are the Best 5GHz Channels for Routers. Routers are very essential in our...

    How to Watch Live TV on Hulu (Expert Guide 2021)

    Streaming has now become a preferable option for consumers. Many of the companies like Hulu, Amazon Prime Video, YouTube TV, and Sling TV has...

    Related articles